References

• 2016Rayyan—a web and mobile app for systematic reviews25,980 cited
• 2021The PRISMA 2020 statement: an updated guideline for reporting systematic reviews13,845 cited
• 2007Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies10,709 cited
• 1997The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials2,052 cited
• 1988An Assessment of Clinically Useful Measures of the Consequences of Treatment1,683 cited
• 1995Practical methodology of meta‐analyses (overviews) using updated individual patient data492 cited
• 2017Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal398 cited
• 2002A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis394 cited
• 2018A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics298 cited
• 2014Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions281 cited
• 2016Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014186 cited
• 2020Multilevel Network Meta-Regression for Population-Adjusted Treatment Comparisons181 cited
• 2015Simulation and Matching-Based Approaches for Indirect Comparison of Treatments